CEO Jaisim Shah retires; Henry Ji appointed CEO and President; Stephen Ma named COO

Semnur Pharmaceuticals, Inc.

Jaisim Shah resigned as CEO, President, and director effective March 13, 2026; retirement not due to any disagreement.
Henry Ji (age 61), formerly Executive Chairperson, appointed CEO and President; also CEO of Scilex (SCLX) and Vivasor.
Stephen Ma, previously CFO and Secretary, appointed COO effective March 17, 2026; also COO of Scilex.
Shah receives six months base salary ($1,250,000/yr) and 90-day extension to exercise vested stock options per separation agreement.
Board size reduced from six to five directors following Shah's resignation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.